NCT05046106View on ClinicalTrials.gov

MLC1501 Study Assessing Efficacy in STROke Recovery

PHASE2/PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

540

Participants

Timeline

Start Date

January 31, 2025

Primary Completion Date

September 30, 2028

Study Completion Date

December 31, 2028

Conditions
StrokeStroke, IschemicStrokes ThromboticStroke SequelaeStroke, CardiovascularStroke, EmbolicStroke, Cryptogenic
Interventions
DRUG

MLC1501

Powdered extract of Radix astragali, Rhizoma chuanxiong, Radix angelica sinensis, Radix polygala

OTHER

Placebo

Caramel, chocolate brown, flavor (E\_1982648), dextrin

All Listed Sponsors
lead

Moleac Pte Ltd.

INDUSTRY